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Phagocytosissolates differ in oncogenic potential in Syrian golden hamsters following
intraperitoneal inoculation. Here we describe the effect of intravenous exposure on tumor induction by
SV40. Strains SVCPC (simple regulatory region) and VA45-54(2E) (complex regulatory region) were highly
oncogenic following intravenous inoculation, producing a spectrum of tumor types. Three lymphoma cell
lines were established; all expressed SV40 T-antigen, were immortalized for growth in culture, and were
tumorigenic following transplantation in vivo. New monoclonal antibodies directed against hamster
lymphocyte surface antigens are described. The cell lines expressed MHC class II and macrophage markers
and were highly phagocytic, indicating a histiocytic origin. Many hamsters that remained tumor-free
developed SV40 T-antigen antibodies, suggesting that viral replication occurred. This study shows that route
of exposure inﬂuences the pathogenesis of SV40-mediated carcinogenesis, that SV40 strain VA45-54(2E) is
lymphomagenic in hamsters, that hamster lymphoid cells of histiocytic origin can be transformed in vivo and
established in culture, and that reagents to hamster leukocyte differentiation molecules are now available.
© 2008 Elsevier Inc. All rights reserved.Introduction
Polyomavirus simian virus 40 (SV40) is an oncogenic DNA virus
that was an inadvertent contaminant of early poliovirus vaccines that
were prepared using cultures of primary monkey kidney cells (Butel
and Lednicky, 1999; Stratton et al., 2003). It is estimated that millions
of people in the US and worldwide received one or more doses of
contaminated vaccines between 1955 and 1963. Exposures may have
occurred beyond that time period, as the USSR oral poliovirus vaccine
may have been contaminated as late as 1978 (Cutrone et al., 2005).
SV40 has been found to be associated with selected human cancers at
varying frequencies, including non-Hodgkin's lymphoma (NHL)
(Amara et al., 2007; Butel, in press; Butel and Lednicky, 1999; Gazdar
et al., 2002; Shivapurkar et al., 2002; Vilchez et al., 2002b; Zekri et al.,
2007); however, other studies have failed to detect an associationregis.vilchez@spcorp.com
m.edu (V. Sroller),
on),
tmed.wsu.edu (W.C. Davis),
ctious Diseases and Dermatol-
ill Road, Kenilworth, NJ 07033,
l rights reserved.(Butel, in press; MacKenzie et al., 2003; Schüler et al., 2006; Sui et al.,
2005). The pathogenesis of SV40 infections in humans has not been
characterized, but lymphoid cells are thought to play an important
role.
The Syrian golden hamster is the animal model for SV40-mediated
oncogenesis because these rodents are highly susceptible to SV40-
induced tumors (Butel et al., 1972; Butel and Lednicky, 1999; Carbone
et al., 1989; Cicala et al., 1993; Diamandopoulos, 1972, 1973; Girardi et
al., 1962). The types of neoplasms that develop in hamsters are
inﬂuenced by the route of inoculation. The spectrum of tumors found
to be SV40-positive in humans is the same as that observed in
hamsters following SV40 inoculation (Gazdar et al., 2002; Vilchez and
Butel, 2004).
It has been shown that biological differences exist among SV40
strains. The distinction of genetic strains is based on sequence
differences in the C-terminal region of the large tumor antigen
(T-ag) gene, which result in amino acid changes in T-ag, the viral
replication protein and the major oncogenic protein (Butel and
Lednicky, 1999; Forsman et al., 2004; Stewart et al., 1996, 1998). In
addition, virus variants can be distinguished by rearrangements in the
viral regulatory region (Lednicky and Butel, 2001). Recent results
showed that SV40 isolates differ in oncogenic potential in hamsters
following intraperitoneal (i.p.) inoculation (Sroller et al., 2008; Vilchez
et al., 2004). The viral regulatory region was found to exert a major
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animals developed tumors following inoculation of viruses with
simple (1E) regulatory regions than those exposed to viruses with
complex (2E) regulatory regions (Sroller et al., 2008). The inﬂuence of
T-ag strain differences was less pronounced, although the SVCPC T-ag
was more oncogenic than either the 776 or VA45-54 T-ag domains.
Together these studies suggest that virus-speciﬁc factors inﬂuence the
oncogenic outcome in an SV40-infected host.
Intraperitoneal inoculation of weanling hamsters often results in
mesotheliomas (Cicala et al., 1993). In contrast, intravenous (i.v.)
inoculation of weanling hamsters reportedly induces leukemias,
lymphomas, and osteosarcomas, as well as undifferentiated sarcomas
(Diamandopoulos, 1972, 1973; Carbone et al., 1989; Cicala et al., 1992).
The lymphomas have been characterized as being of B cell or
histiocytic and macrophage origin (Carbone et al., 1989; Cicala et al.,
1992; Coe and Green, 1975).
An evaluation of the oncogenicity of different SV40 strains
administered via i.v. inoculation has not previously been performed.
Characterization of SV40-mediated lymphomagenesis in hamsters
may elucidate viral effects on lymphoid cells that will provide insights
into a possible role of SV40 in human lymphoid tumors. Additionally,
this model will allow for studies of a role that infected lymphoid cells
may play in disseminating virus in a host. This report describes tumor
induction in hamsters following i.v. inoculation of SV40, the develop-
ment of monoclonal antibodies useful to characterize surface markers
of hamster lymphoid cells, and the derivation and characterization of
SV40 lymphoma tumor cell lines. We focused on SV40 strains SVCPC,
highly oncogenic by the i.p. route of inoculation (Sroller et al., 2008;
Vilchez et al., 2004), and VA45-54, used in the original studies of i.v.
administration of SV40 (Diamandopoulos, 1972, 1973).
Results
Tumor induction in hamsters following i.v. inoculation of SV40
To study the process of SV40-induced lymphomagenesis in the
hamster model, groups of 21-day-old Syrian golden hamsters were
inoculated intravenously with 1×107 PFU of SV40. Viral strain-
dependent tumorigenicity following this route of administration was
evaluated by comparing two well-characterized strains, SVCPC and
VA45-54. The latter virus had been found by Diamandopoulos (1972,
1973) to be lymphomagenic. To determine if unique T-ag sequences
play a role in tumorigenesis following i.v. inoculation, recombinant
viruses were included in which the T-ag C-terminal coding region
(T-ag-C) from strains SVCPC and VA45-54were present on the 776(2E)Table 1
Tumor development in Syrian golden hamsters following intravenous inoculation with SV4
Virus No. tumors/no. necropsied
animals (% tumors)
No. tumors+ late deaths/
No. animals (% tumors)
SVCPC 3/6 (50) 6/9 (67)
VA45-54(1E) 2/12 (17) 5/15 (33)
VA45-54(2E) 9/12 (75) 14/17 (82)
776-CPC(2E) 2/13 (15) 2/13 (15)
776-VA(2E) 3/9 (33) 10/16 (62)
Totals: 19/52 (36) 38/71 (54)
Controls
(TC7 cell lysate)
0/28 (0) 0/28 (0)
a 1×107 PFU of each virus was inoculated intravenously into 21-day-old weanling hamster
assumed to reﬂect complications of surgery and were removed from the group count. Both
without a necropsy are reported.
b Tumors from 12 animals were examined histologically; tumors contained mixtures of t
c Sarcoma = poorly differentiated sarcoma.strain background, 776-CPC(2E) and 776-VA(2E). The role of the viral
regulatory region on oncogenicity was examined by inclusion of single
(1E) and double (2E) enhancer viruses, including both versions of
strain VA45-54.
Inoculated animals were sacriﬁced at 22–34 weeks (5–8 months)
postinoculation (p.i.) (Table 1). In each group, some animals died
2 months or later p.i. but were not necropsied. It is likely that these
animals had tumors that caused the unexplained deaths, as such
deaths were not observed in the control groups in this or previous
studies (Sroller et al., 2008; Vilchez et al., 2004). Animal deaths less
than 4weeks p.i. were assumed to reﬂect complications of the surgical
inoculation procedure and were removed from the animal counts.
Tumor incidences have been calculated by both including and
excluding the unnecropsied late (≥2 months p.i.) deaths (Table 1).
Both SV40 strains SVCPC and VA45-54(2E) were highly oncogenic
by the i.v. route of inoculation. SVCPC produced tumors in 50% of
necropsied animals and that tumor incidence reached 67% (6/9) when
late deaths were included. Strain VA45-54(2E) was most oncogenic,
with tumors (conﬁrmed at necropsy) in 75% (9/12) of the animals.
Including late deaths, 14 of 17 (82%) animals of this group were
affected. In contrast, the single-enhancer version of this virus [VA45-
54(1E)] was much less oncogenic. Only 17% (2/12) of the necropsied
animals in this group developed tumors, or 33% (5/15) when late
deaths were also considered. This observation suggests that the
rearranged regulatory region of the two-enhancer virus [VA45-54
(2E)] may be an important factor in oncogenesis via the i.v. route of
inoculation.
Results obtained with the recombinant constructs revealed a trend
suggesting that tumor incidence may be inﬂuenced by the parental
virus background. Only 33% (3/9) of necropsied animals had tumors
following i.v. inoculation of 776-VA(2E) compared to 75% for VA45-54
(2E), even though the inoculated viruses shared the same T-ag-C
coding region and both had complex regulatory regions. When total
numbers of animals with tumors were taken into account (necropsied
+ late deaths), the tumor incidence was 10 of 16 (62%) for 776-VA(2E),
compared to 14 of 17 (82%) for VA45-54(2E). A comparison of tumor
development by the matched recombinants 776-VA(2E) and 776-CPC
(2E) revealed that the VA45-54 T-ag appeared to be more tumorigenic
than the SVCPC T-ag [(3/9, 33% vs. 2/13, 15%; p=0.30) in necropsied
animals, respectively, and (10/16, 62% vs. 2/13, 15%; p=0.01) when late
deaths are included].
The morphologic types of tumors that developed following i.v.
inoculation were identiﬁed by histologic examination of available
preserved specimens (Table 1). Representative images of the different
histologic types of tumors, including mesothelioma, lymphoma,0 parental strains and recombinant virusesa
Median time to tumors, weeks
(range)
Histologic types of tumorsb
Necropsied
animals
Necropsied+
late deaths
24 (22–24) 21 (8–24) Mesothelioma, malignant ﬁbrous
histiocytoma (2), lymphoma,
osteosarcoma, sarcomac
34 (34) 26 (13–34) Not done
28 (24–33) 27 (20–33) Osteosarcoma, malignant ﬁbrous
histiocytoma (2), sarcoma, lymphoma
30 (30) 30 (30) Mesothelioma
30 (24–34) 28 (23–34) Mesothelioma
s and animals were observed for 8 months. Animals that died less than 4 weeks p.i. were
necropsy-proven tumors and animals that died more than 2 months p.i. (late deaths)
ypes.
Fig. 1. Representative tumor types that developed following i.v. inoculation of SV40. Sections of hamster tissue were collected at necropsy, formalin ﬁxed, and stained with
hematoxylin and eosin. (A) Mesothelioma tissue is characterized by inﬁltrative mass of atypical round to spindle cells often having papillary structures that are lined in one layer of
round to cuboidal medium-sized cells with prominent nuclei. (B) Lymphoma tissue appears as highly cellular tumor tissue composed of homogeneous round cells that often have an
indented nucleus andmultiple nucleoli. (C) Osteosarcoma tissue is composed of atypical pleomorphic cells that are stellate, pyriform, and polyhedral, with tumor cells often oriented
around small spicules of pale osteoid. There are also numerous fragments of bone in this section that are not decalciﬁed. (D) The spindle cell carcinoma shown has an inﬁltrative mass
into muscle composed of atypical enlongate to spindle cells with prominent nuclei and multiple nucleoli.
116 A.L. McNees et al. / Virology 384 (2009) 114–124osteosarcoma, and spindle cell sarcoma, are shown in Fig. 1. Multiple
mesenchymal tumors including lymphomas, were often observed
within a single malignancy. The morphologic diagnosis malignant
ﬁbrous histiocytoma was made on several of the tumors (not shown).
This is a pleocellular neoplasm that presumably arises from primitive
mesenchymal cells.
Immune response to SV40 T-ag
At the time of necropsy, blood was collected from each animal and
serum samples were assayed by indirect immunoﬂuorescence to
measure antibody responses to SV40 T-ag (Table 2). The majority of
tumor-bearing animals produced detectable levels of T-ag-speciﬁcTable 2
Antibody responses to SV40 T-ag in Syrian golden hamsters inoculated intravenously
with SV40
Virus regulatory
region
Presence
of tumors
No. positivea/no. tested (%)
Intravenous
inoculationb
Intraperitoneal
inoculationc
2E (complex) Yes 13/14 (93) 18/18 (100)
No 20/20 (100)d 99/136 (73)e
1E (simple) Yes 5/5 (100) 57/64 (89)
No 11/13 (85)d 35/86 (41)e
a Antibodies to SV40 T-ag were detected using an indirect immunoﬂuorescence assay
(Vilchez et al., 2004).
b Sera were collected when tumor-bearing animals were sacriﬁced or when
experiment was terminated 8 months after inoculation. Sera were not available from
animals that died without necropsy.
c From Sroller et al. (2008).
d p=0.0001.
e p=0.0001.antibody (93% for double-enhancer viruses and 100% for single-
enhancer viruses). Median antibody titers for positive sera were
similar: 100 (range 5–1000) and 100 (range 10–5000) for tumor-
bearing animals exposed to 2E and 1E viruses, respectively. In
contrast, viruses with complex or simple regulatory regions differed
in their induction of T-ag-speciﬁc antibodies in non-tumor-bearing
animals (20/20, 100% vs. 11/13, 85%, p=0.0001). In addition, the
median antibody titers in the non-tumor-bearing animals were 100
(range 5–1000) for those inoculated with 2E viruses and 10 (range
5–1000) for those exposed to 1E viruses. None of the control animals
tested (n=12) had detectable anti-T antibody levels. The antibody
responses by the tumor-free animals following i.v. inoculation were
similar to those observed in a previous study in which hamsters were
inoculated i.p. (Sroller et al., 2008); 73% of non-tumor-bearing animals
produced anti-T-ag antibody following i.p. inoculation of two-
enhancer viruses, as compared to 41% for those exposed to single-
enhancer viruses (p=0.0001).
Hamster lymphoma cell lines
Enlarged spleens were observed at necropsy in several of the
animals. Hamster 1087 had been inoculated with VA45-54(2E) and
hamsters 1109 and 1113 with 776-VA(2E) (Table 3). The splenomegaly
was greatest in hamster 1113 (Fig. 2). Splenomegaly may occur as part
of the spleen's normal functions in immunosurveillance and hema-
topoiesis, lymphoproliferation in response to viral infections, or
inﬁltrations of leukemic or lymphoma cells. Histologic examination
of the spleens fromwhich the cell lines were derived revealed various
types of tumor cells. The spleen sections from hamsters 1109 and 1113
that had been inoculated with SV40 strain 776-VA(2E) (Table 3)
revealed ﬁbrous sarcoma cells. The spleen fromhamster 1087 that was
Table 3
Characteristics of established hamster lymphoma cell lines
Hamster no. SV40 strain
inoculated
Sacriﬁced
(months p.i.)
Cell line
designationa
Virus production
(passage no.)b
Viral genomes per cell
(passage no.)b
Ratio of early to late
SV40 mRNA (passage no.)b
T-antigen
expression
1087 VA45-54(2E) 6 S1087 No (P2) 4 (P6) 55 (P31) Yes
1109 776-VA(2E) 6 S1109 No (P2) 7 (P4) 43 (P31) Yes
1113 776-VA(2E) 8 S1113 No (P2) 6 (P1) 15 (P33) Yes
a Cell lines established from enlarged spleens of hamsters.
b Passage no., passage level of the cell line tested.
117A.L. McNees et al. / Virology 384 (2009) 114–124inoculated with VA45-54(2E) contained a hematoma with extrava-
sated erythrocytes and occasional foci of lymphocytes consistent with
lymphoma. It is possible that the spleen sections available for
microscopic examination did not contain the malignant cells that
gave rise to the established lymphoma cell lines.
Single-cell suspensions were prepared from the enlarged spleens
and cultured as described in Materials and methods. Cell lines were
established and designated by the hamster number from which they
were derived (S1087, S1109 and S1113). All three cell lines were
immortalized in vitro as evidenced by long-term growth in tissue
culture (N55 passages). Each cell line displayed a relatively hetero-
geneous morphology at all passage levels in which some cells were
weakly adherent to the culture ﬂask and others remained in
suspension.
To rule out the possibility that the splenomegaly observed in the
hamsters was related to an antiviral response to active replication of
SV40, cells were analyzed for the production of infectious virus. Early
passages (P2) of each of the three cell lines were subjected to three
cycles of freezing and thawing and the lysates were tested for
infectious virus by plaque assay. Infectious SV40 was not detected in
any of the cell lines (Table 3).
SV40 DNA was quantiﬁed in the lymphoma cell lines using real-
time quantitative PCR (RQ-PCR) to amplify T-ag DNA sequences. These
values were normalized to cell number as determined by counting
cells in a hemacytometer. A range of 4–7 copies per cell of SV40 DNA
was detected in the cell lines (Table 3). Quantiﬁcation of early (T-ag)
and late (VP1) viral mRNAs revealed that both early and late
transcripts were produced, with the ratio of early-to-late message
ranging from 15- to 55-fold among the cell lines (Table 3). The low
levels of late mRNA detected combined with the observations of low
genome copy numbers and the absence of infectious virus production
indicate that the cell lines were not supporting active virus replication
(Ernoult-Lange and May, 1983).Fig. 2. Spleens harvested from tumor-free hamsters (A) and 1113 (B), each at 8 months
after i.v. inoculation with SV40 strain 776-VA(2E).SV40 T-ag is the major transforming protein of the virus and its
expression is likely involved in the immortalized phenotype of the
hamster lymphomas. Expression of SV40 T-ag was conﬁrmed in all
three cell lines using monoclonal antibodies speciﬁc for T-ag in both
ﬂow cytometry and immunohistochemistry (IHC) assays. Flow
cytometry revealed that all three cell lines uniformly expressed high
levels of intracellular T-ag (Figs. 3A–C) and relatively low levels of
surface T-ag (Figs. 3D–F). IHC staining conﬁrmed that nearly all cells in
the established cell lines expressed intranuclear T-ag (not shown). VP1
expression in the cell lines was not detected by immunoﬂuorescence
using anti-SV40 VP1 rabbit serum (data not shown).
Derivation of monoclonal antibodies speciﬁc to hamster lymphocytes
There are few commercially available immunological reagents
that react with subsets of hamster lymphocytes. Monoclonal
antibodies (mAbs) speciﬁc to hamster lymphocyte markers were
developed as described in Materials and methods and were used to
identify surface antigens of the lymphoma cell lines. Available
antibodies displayed speciﬁcities directed to epitopes on the class II
major histocompatibility complex (MHC) molecules and markers of
B, T, and dendritic cells (Table 4). The optimal working dilution of
hybridoma supernatants was determined by staining primary
hamster splenocytes and peripheral blood lymphocytes followed
by ﬂow cytometric analysis (data not shown).
Identiﬁcation of lymphoma cell lines of histiocytic origin
Hamster lymphoma cell lines S1109, S1113 and S1087 and control
primary hamster splenocytes were stained with the anti-hamster
monoclonal antibodies and were analyzed by ﬂow cytometry (Fig. 4).
All the described anti-hamster monoclonal antibodies recognized
subpopulations in the primary hamster lymphoid cells (Fig. 4A). The
percentage of positive cells for each antibody is shown in Table 4. All
three cell lines were negative for expression of B-cell-speciﬁc epitopes
recognized by HASA7A (Figs. 4B–D) and HAL24A (data not shown).
None of the cell lines expressed T cell epitopes recognized by HAL3A,
HAT19A (Figs. 4B–D), and HAT24A (data not shown). The cell lines
expressed relatively high levels of class II MHC molecules, shown by
reactivity with monoclonal antibodies HAL4A, HAL16A, HAT16A,
HAT17A (Figs. 4B–D), and H42A (data not shown). Cell line S1113
showed the highest expression of a class II MHC epitope recognized by
HAL4A, followed by S1087, whereas binding was undetected on S1109.
A dendritic cell marker was not detected on any of the cell lines using
antibody HAB4A. None of the cell lines reacted with the HAB6A
monoclonal that is speciﬁc for a pan lymphocyte marker (data not
shown). All three of the cell lines expressed relatively high levels of a
CD45 homologue recognized by HASA25A, and a CD18 homologue
recognized by BAQ30A (Figs. 4B–D) (Saalmüller et al., 2005).
To further evaluate the possibility that the hamster lymphoma cell
lines might be of B-cell origin, cells were stained with an anti-hamster
Ig reagent that recognized the heavy chain of Ig that would be part of a
hamster B-cell receptor. Surface Ig was not detected on any of the
three lymphoma cell lines. This observation was in agreement with
the negative results obtained with the B-cell-speciﬁc monoclonals,
HASA7A (Fig. 4) and HAL24A. The cell lines were also stained with the
Fig. 3. Expression of SV40 T-ag detected by intracellular staining or surface staining and ﬂow cytometry on hamster lymphoma cell lines S1109 (Panels A, D), S1113 (Panels B, E), and
S1087 (Panels C, F). Intracellular expression (Panels A–C) was detected using PAb101 (black lines); negative control staining was done with mouse IgG2a (gray lines). Surface
expression (Panels D–F) of SV40 T-ag was detected using PAb416 (black lines); negative control staining was done with IgG2a (gray lines).
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are speciﬁc for a subpopulation of mouse mononuclear phagocytes,
includingmacrophages, and reported to cross-react with hamster cells
(Carbone et al., 1989). All three lymphoma cell lines were positive for
MAC-2 and MAC-3 expression, although MAC-3 levels were relativelyTable 4
Derivation and characterization of monoclonal antibodies reactive to hamster
lymphocytesa
Clone
name
Immunogenb % Pos.
splenocytes
IgG
subclass
Speciﬁcity
H42A PBMCs from
multiple species
50c IgG2a Class II MHC
HAL4A Lymph node
Mononuclear cells
36c IgG3 Class II MHC
HAL16A Lymph node
Mononuclear cells
48c IgG1 Class II MHC
HAT16A Thymocytes 67 IgG2b Class II MHC
HAT17A Thymocytes 40 IgG1 Class II MHC
HAB4A Peripheral blood
leukocytes
18c IgG1 Dendritic cell
HAT24A Thymocytes 12c IgG1 T cell
HAL3A Lymph node
Mononuclear cells
29c IgG2a T cell
HAL9A Lymph node
Mononuclear cells
1 IgG1 T cell
HAB1A Peripheral blood
leukocytes
0.3 IgG1 T cell
HAT19A Thymocytes 14 IgG2a T cell
HASA7A Mononuclear splenocytes 33 IgG1 B cell
HAL24A Lymph node
Mononuclear cells
6 IgG2a B cell
HAB6A Peripheral blood
leukocytes
42 IgG2a Pan
lymphocyte
HASA25A Mononuclear splenocytes 91 IgG1 CD45
BAQ30A PBMCs from multiple
species
75 IgG1 CD18
a Washington State University Monoclonal Antibody Center.
b Derived from normal tissues of Syrian golden hamsters.
c Average of three or more experiments.lower on cell lines S1109 and S1113 (Figs. 4B–D). Taken together, the
detection of epitopes speciﬁc for macrophages and class II MHC
molecules suggested that the SV40-transformed cell lines were
derived from a histiocytic lineage.
Functional assays were conducted to determine if the hamster
lymphoma cell lines displayed phagocytic properties, characteristic of
macrophage and dendritic cells. Primary hamster splenocytes and the
S1113, S1109 and S1087 cell lines were incubated with ﬂuorescent
polystyrene beads at either 4 or 37 °C and analyzed by ﬂow cytometry
at 0 and 120 min after addition of the beads (Fig. 5). The human
monocyte-macrophage cell line (MM6) was used as a positive control
for phagocytic cells (data not shown) and primary hamster spleno-
cytes served as nontransformed controls. All three hamster lymphoma
cell lines were capable of taking up the beads at 37 °C, as greater than
70% of the cells were positive (Fig. 5). Cells incubated at 4 °C retained
viability but failed to phagocytose beads, ruling out nonspeciﬁc
surface sticking and showing that the positive results obtained at 37 °C
were due to active uptake of beads. Primary hamster splenocytes
failed to exhibit detectable levels of phagocytosis at either tempera-
ture. High levels of bead uptake were apparent by each of the hamster
lymphoma cell lines without activation treatments. Confocal micro-
scopy conﬁrmed the intracellular localization of phagocytosed beads
and showed that some cells ingested multiple beads (Fig. 6).
Functional phagocytic activity supports the interpretation that the
transformed lymphoma cell lines are of histiocytic origin.
Transplantability of SV40-positive hamster lymphoma cell lines
The ability of transformed cells to develop into tumors after being
injected into animals is a conventional phenotypic characterization to
indicate if malignant transformation has occurred. The tumor
incidence and time required for tumor development following
inoculation of transformed cells are often related to the cell dose of
the inoculum (Lewis et al., 1999; Tevethia and Butel, 1973). To
determine if the hamster lymphoma cell lines were tumorigenic,
weanling hamsters were inoculated with various doses of lymphoma
119A.L. McNees et al. / Virology 384 (2009) 114–124cells and observed for tumor growths. Each of the three cell lines was
capable of inducing solid tumor growths near the subcutaneous site of
injection following inoculation of ≥1×106 cells, demonstrating that
the lymphoma cell lines are tumorigenic in intact animals.
Discussion
This study addressed tumor induction by different strains of SV40
in the Syrian golden hamster model following inoculation by the i.v.
route. Previous studies have shown that the types of tumors induced
by SV40 in hamsters are inﬂuenced by the route of inoculation (Butel
and Lednicky, 1999; Cicala et al., 1993; Diamandopoulos, 1973).
Recently, it has been demonstrated that viral strains differ in the
frequency of tumor formation when virus is delivered intraperitone-
ally (Sroller et al., 2008). This study conﬁrmed that SV40 is highly
oncogenic by the i.v. route (Carbone et al., 1989; Cicala et al., 1993;
Diamandopoulos, 1972, 1973), and it revealed that tumor formation is
inﬂuenced by a combination of factors, including route of exposure
and virus strain.
Our previous study demonstrated the signiﬁcantly greater onco-
genicity of viruses with simple regulatory regions (1E) compared to
those with complex, rearranged regulatory regions (2E) when
inoculated i.p. into weanling hamsters (Sroller et al., 2008). This was
not observed in the present study with strain VA45-54 following i.v.
inoculation. The viral dose (1×107 PFU) was the same in both studies,
as was the age of the recipient hamsters (21-day-old weanlings), so
the different patterns of oncogenicity must reﬂect the inﬂuence of the
route of inoculation. Strain VA45-54(2E) was more tumorigenic than
its one-enhancer counterpart (75% vs. 17% of necropsied animals).
However, strain SVCPC, a single-enhancer virus that was highly
oncogenic by the i.p. route, retained high oncogenicity by i.v.
inoculation. To conﬁrm that no mix-up had occurred with the VA45-
54 viruses, several tumors were analyzed by PCR using SV40
regulatory region primers. Tumors were found to contain the
appropriate regulatory region (1E or 2E) for the virus variants that
were inoculated.
Analysis of the results obtainedwith strain 776-based recombinant
viruses suggests that the 776 background lessens the oncogenicity of
the VA45-54 strain. Whereas VA45-54(2E) induced tumors in 75% of
hamsters, that incidence dropped to 33% when the T-ag region was
transferred to a 776(2E) background. This approximate 2-fold
reduction in tumor incidence with the same recombinant relative to
parental VA45-54(2E) was also observed following i.p. inoculation
(Sroller et al., 2008). These observations might reﬂect functioning of
the viral regulatory regions in hamster cells. However, it is possible
that SV40 small t-antigen (t-ag) may be functionally involved. The
recombinant constructs utilized in this study contained the small t-ag
coding region of the backbone virus (i.e., strain 776). There are two
amino acid differences in small t-ag between SVCPC and 776 (residues
95 and 109) and three differences in small t-ag between VA45-54 and
776 (residues 95, 104 and 109) (Stewart et al., 1996). An effect of small
t-ag on SV40 oncogenicity in hamsters has been reported (Carbone et
al., 1989; Cicala et al., 1992; Matthews et al., 1987). Whereas wild-type
virus induces a variety of tumor types, small t-ag deletion mutants
preferentially induced lymphoidmalignancies, suggesting that a small
t-ag function is required for SV40 transformation of nondividing cells
in vivo. Future studies are needed to address a potential role of the
small t-ag in VA45-54 oncogenicity.
A broad spectrum of tumor types was obtained in this study
following i.v. inoculation of SV40, as observed previously by others
(Cicala et al., 1993; Diamandopoulos, 1972, 1973). A likely explanation
is that the i.v. route efﬁciently delivers the virus into contact with a
variety of susceptible cell types throughout the host. This is supported
by the general trend of increased oncogenicity by SV40 strains
following i.v. inoculation as compared to i.p. administration. For
example, strain VA45-54(2E) was highly oncogenic when inoculatedi.v. (75% of necropsied animals) but less so when inoculated i.p. (20–
23%) (Sroller et al., 2008; Vilchez et al., 2004).
The majority of non-tumor-bearing animals produced durable
antibodies to SV40 T-ag that were detectable at the termination of the
experiments described here. We suggest that this high-frequency
antibody response to T-ag in the absence of tumors reﬂects viral
replication in some unidentiﬁed cells in the hamsters. Notably, the
exposure to viruses with complex regulatory regions and viruses with
single enhancers resulted in a statistically different frequency of T-
antibody production (p=0.0001). This is in agreement with what had
been observed following i.p. inoculation (Sroller et al., 2008). We
speculate this difference in T-antibody production in non-tumor-
bearing animals reﬂects dissimilar rates of SV40 replication and host
response to infection between viruses with simple and complex
regulatory regions. This hypothesis is supported by studies in cell
culture which have shown that SV40 viruses with complex regulatory
regions replicate faster and to higher titers than those with simple
regulatory regions (Lednicky and Butel, 1997). In addition, studies
with murine polyoma virus have shown that faster-growing viral
variants are associated with high viral replication and a strong
immune response, whereas slower-growing variants persist with low-
level viral replication and no notable host response (Rochford et al.,
1992).
This investigation conﬁrmed that lymphoid cells can be malig-
nantly transformed in vivo by SV40 under certain conditions
(Carbone et al., 1989; Cicala et al., 1992; Diamandopoulos, 1972,
1973). Three spleen-derived lymphoma cell lines were established
and found to be immortalized and tumorigenic. This in vivo
transformation may predict a common outcome of SV40 infection
of lymphocytes as the same types of tumors were induced in three
out-bred animals, inoculated with two variants of SV40. It showed
that cells of the monocyte lineage are susceptible to infection by
wild-type SV40, as reported for a small t-ag deletion mutant of the
virus (Carbone et al., 1989; Matthews et al., 1987). As surface
immunophenotyping provides a direct method for characterizing
populations of lymphoid cells, the newly developed anti-hamster
antibodies described here were valuable tools for analyzing cells
susceptible to infection and transformation in vivo by SV40. All three
lymphoma cell lines appear to possess characteristics of histiocytic
origin, including the ability to phagocytose particles, expression of
high surface levels of MHC class II, and expression of the MAC-2 and
MAC-3 antigens, markers of a subpopulation of mouse mononuclear
phagocytes previously detected on other hamster lymphomas
(Carbone et al., 1989; Cicala et al., 1992).
This study demonstrated the lymphomagenic property of SV40
strain VA45-54, the viral isolate utilized by Diamandopoulos (1972,
1973) in the original descriptions of lymphoma induction in hamsters
by SV40. The virus is not exclusively lymphomagenic, as other types of
malignancies, such as osteosarcomas, also developed. It remains to be
determined what physiologic processes or viral characteristics
contribute to lymphomagenesis by this strain when inoculated
intravenously. Perhaps SV40 particles were internalized by circulating
cells of histiocytic origin, such as monocytes, that trafﬁcked to the
spleen and differentiated into mature cells. Alternatively, other cells
may have carried the virus to the spleen (and other organs) where
target cells, such as the monocyte-derived cells recovered here,
became infected. Expression of the VA45-54 early region presumably
contributed to cell proliferation and transformation, and expression of
the viral early proteins may have been inﬂuenced by the rearranged
regulatory region of VA45-54(2E). This working model of SV40-
induced lymphomagenesis will guide future studies into which
additional hamster lymphocyte subsets are susceptible to SV40-
induced infection and transformation and may provide insights into
SV40 association with human lymphomas. The tumorigenic hamster
lymphoma cell lines described here that retain phenotypic properties
of cell origin will be valuable tools with which to study tumor
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Fig. 5. Phagocytosis by hamster lymphoma cell lines measured by ﬂow cytometry. The percentage of cells that internalized ﬂuorescent-labeled beads, averaged from two
independent experiments, are graphed with standard error of the mean. Control samples were incubated at 4 °C. The average viability for each sample from both experiments is
shown below the graph.
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regimens for lymphomas.
Materials and methods
Viruses
SV40 strains to evaluate tumorigenicity following i.v. inoculation
into hamsters included: SVCPC (GenBank, AF156108) and VA45-54,
variants 1E and 2E (GenBank, AF156105). In addition, recombinant
viruses were included: 776-CPC(2E) and 776-VA(2E). These recombi-
nants were generated by cloning the large T-ag variable domain (T-ag-
C) sequence from SVCPC and VA45-54, respectively, into the genome
of SV40 strain 776 with a complex (2E) regulatory region (Sroller et al.,
2008). Virus stocks were produced and quantiﬁed in TC-7 cells (Butel
et al., 1999). Strain 776 was isolated from an adenovirus type 1 vaccine
seed stock (Sweet and Hilleman, 1960). Strain VA45-54 was originally
isolated from cultures of primary monkey kidney cells (Girardi et al.,
1962) and has been detected in a human osteosarcoma (Lednicky et
al., 1997). Strain SVCPC, with a simple (1E) regulatory region, has been
isolated twice from human brain tumors (Krieg and Scherer, 1984;
Lednicky et al., 1995) and has been detected in several human
malignant specimens (Arrington et al., 2004; Vilchez et al., 2002a,
2002b). Both strains, VA45-54 and SVCPC, were found in the USSR
poliovaccine seed stock (Cutrone et al., 2005).
Induction of tumors in hamsters
Weanling 21-day-old male and female Syrian golden hamsters were
purchased from Harlan Sprague Dawley (Indianapolis, IN) and were
housed in the biohazard facility at the Center for Comparative Medicine
at Baylor College of Medicine. These studies were approved by the
Institutional Animal Care and Use Committee at Baylor College of
Medicine. Animals were maintained according to approved protocols
and all care was in accordance with established national guidelines as
outlined in DHEW Publication No. (NIH) 78-23, “Guide for the Care and
Use of Laboratory Animals”. Using aseptic techniques, experimentalFig. 4. Surface expression of epitopes speciﬁc for lymphocyte subpopulations detected by
hamster lymphoma cell lines. For all histograms, negative controls are shown by gray lines rep
antibody. Cells stained with the speciﬁc anti-hamster antibodies are color-coded to the histo
for assays with all monoclonal antibodies except MAC-2, for which primary hamster periphanimals under anesthesia were inoculated via the femoral vein with
1×107 PFU of virus in 0.2 ml. Control animals were inoculated similarly
with lysates of uninfected TC7 cells. Animals were observed thrice
weekly andwere sacriﬁcedwhen therewas evidence of illness or tumor
formation or at 8 months p.i. at the termination of the experiment.
Necropsy was conducted following exsanguination by cardiac puncture
with the animals anesthetized. Samples of normal and tumor tissue
were collected, ﬁxed in 10% buffered formalin, and parafﬁn embedded.
Tissue sections were stained with hematoxylin and eosin and examined
microscopically without knowledge of virus inoculum.
Establishment of splenocyte-derived cell lines
Enlarged spleens were observed in several animals. Single-cell
suspensions were prepared by pushing fresh spleen tissue through a
cell strainer (Falcon) into RPMI 1640 media (Gibco) supplemented
with 10% fetal calf serum and insulin-transferrin-sodium selenite
(Sigma). Cells were collected and incubated for 5 min at 25 °C in red
cell lysis buffer (10 mM KHCO3, 150 mM NH4Cl, 0.1 mM EDTA pH 8.0).
The recovered lymphocytes were washed and cultured in the same
RPMI media. Cells were dissociated from ﬂasks by pipetting or using
cell scrapers (Sarstedt) and were subcultured once or twice per week
for up to 60 passages.
Assays for SV40 DNA, RNA and infectious virus in hamster
lymphoma cell lines
Cellular DNA was extracted following a proteinase K/phenol
extraction protocol (Lednicky and Butel, 1998). RQ-PCR to detect and
quantify SV40 DNA genome contents was performed as described
(McNees et al., 2005). To quantify viral transcripts, total RNA was
extracted from the lymphoma cell lines, using the RNAqueous-4PCR
isolation kit (Ambion) followed by DNAse I treatment. RNA was
reverse transcribed using the SuperScript III First-Strand Synthesis
System for RT-PCR kit (Invitrogen)with random hexamer primers. The
SV40 early mRNAs and late mRNAs were detected by PCR using ﬁrst-
stranded cDNA and primer sets SVEARL1/2 and SVLATE1/2, designedﬂow cytometry. (A) Primary hamster lymphoid cells; (B–D) Established SV40-positive
resenting unstained cells and black lines representing cells stained onlywith secondary
grams. Primary splenocytes from uninoculated hamsters were used as normal controls
eral blood mononuclear cells were used as controls.
Fig. 6. Internalization of phagocytosed beads by hamster lymphoma cell lines
measured by confocal microscopy. Cells are shown 120 min after the addition of 30
ﬂuorescent-labeled beads per cell and incubation at either 4 °C (Panels A, C, E) or 37 °C
(Panels B, D, F). Shown are hamster cell lines S1109 (Panels A, B), S1113 (Panels C, D),
and S1087 (Panels E, F). Original magniﬁcation, 20×.
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be identiﬁed on gels. Quantiﬁcation of SV40 early and late transcripts
wasmade by RQ-PCR using the above cDNAs and targeting the large T-
ag gene and the VP1 gene (McNees et al., 2005). An endogenous
control was used for normalization by amplifying 18S ribosomal RNA
using primers and probe targeting a sequence conserved across manyTable 5
Sequences of primers and probes used in conventional PCR and RQ-PCR assays
Oligonucleotides (5′→3′)a Re
PCR, SV40 early region
SVEARL1: CAGCAGTAGCCTCATCATCAC nt
SVEARL2: GCAGCTAATGGACCTTCTAGGTCT nt
PCR, SV40 late region
SVLATE1: CTCCGTTAAGGTTCGTAGGTC nt
SVLATE2: CCTCAGTGAAGCTGTCTACTC nt
RQ-PCR, SV40 early region, SVPENT primers and probe
FP: GATGGCATTTCTTCTGAGCAAA nt
RP: GAATGGGAGCAGTGGTGGAA nt
Probe: FAM-CAGGTTTTCCTCATTAAA-MGB nt
RQ-PCR, SV40 late region, SVVP1 primers and probe
FP: GGGCCCTTGTGCAAAGC nt
RP: GTTGGTAAACAGCCCACAAATG nt
Probe: VIC-ACAGCTTGTATGTTTCTG-MGB nt
RQ-PCR, human 18S ribosomal RNA
FP: TCGAGGCCCTGTAATTGGAA N/
RP: CCCTCCAATGGATCCTCGTT
Probe: FAM-AGTCCACTTTAAATCCTT-MGB
a FP = forward primer; RP = reverse primer.
b Reference nucleotide positions in SV40 strain 776 (SV40-776).
c PCR annealing temperature. N/A = not applicable.species (Jelinek and Prchal, 2004). RNA processed without reverse
transcriptase served as control for SV40 DNA contamination of RNA
samples. Primer and probe sequences are shown in Table 5. Rescue of
infectious virus from the hamster lymphoma cell lines was attempted
as described (Sroller et al., 2008).
Detection of SV40 T-ag by ﬂow cytometry
Intracellular and surface expression of SV40 T-ag was detected in
the hamster lymphoma cell lines by ﬂow cytometry. Intracellular
staining was performed by ﬁxing cells in 2% paraformaldehyde for
10 min at 37 °C, followed by 90% ice-cold ethanol overnight. Cells
were washed with 1% bovine serum albumin (BSA) in phosphate
buffered saline (PBS) and resuspended in the same buffer containing
anti-T-ag monoclonal antibody PAb101 (Santa Cruz Biotechnology).
Cells were incubated at 25 °C for 30 min, washed, and resuspended
in buffer containing goat anti-mouse F(ab)′2-phycoerithrin (PE)
(Southern Biotechnology Associates). For surface staining of T-ag,
unﬁxed cells were stained on ice for 30 min with PAb416 (Oncogene
Research Products) followed by goat anti-mouse F(ab)′2-PE. All
samples were analyzed at the Flow Cytometry Core Facility at Baylor
College of Medicine using a Beckman Coulter EPICS XL-MCL and
FlowJo software (FlowJo, LLC, Ashland, OR).
Detection of SV40 VP1 by immunoﬂuorescence
Staining for VP1 was performed by preparing Shandon Cytospin
slides (Thermo Fisher Scientiﬁc) with each hamster lymphoma cell
line for immunoﬂuorescence staining per the manufacturer's recom-
mendations. Slides were processed as described previously and
stained with anti-SV40 VP1 rabbit serum (Butel et al., 1984). A positive
control of permissive SV40-infected TC7 cells was included, as well as
two negative controls that were stained with either ﬂuorescein
isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin
(Ig) only, or with an anti-intact mouse mammary tumor virus rabbit
serum followed by FITC-goat anti-rabbit.
Monoclonal antibodies against hamster lymphocytes
Mouse mAbs speciﬁc to hamster leukocyte differentiation mole-
cules (hLDM) were produced by the Washington State University
Monoclonal Antibody Center in the College of Veterinary Medicine,ference positionsb Temperature (°C)c Size (bp) PCR product
4463–4483 52 669, viral DNA
5131–5108 602, small t-ag cDNA
322, large T-ag cDNA
364–384 52 1283, viral DNA
1646–1626 346, 16S RNA cDNA
4486–4507 N/A N/A
4550–4531
4509–4526
2258–2274 N/A N/A
2323–2302
2277–2294
A N/A N/A
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from 4 sets of BALB/c mice immunized with preparations of hamster
peripheral blood leukocytes (HAB), thymocytes (HAT), lymph node
mononuclear cells (HAL), or a mixture of nonadherent and adherent
mononuclear splenocytes (HASA). Following 4 subcutaneous injec-
tions of 4×106 cells given every 2 weeks, the mice were given a ﬁnal
booster injection intravenously 3 days before spleen cells were
harvested and fused with X63 Ag8.653 myeloma cells (Hamilton and
Davis, 1995). Flow cytometry was used to screen the primary culture
supernatants for hybridomas producing mAbs to hLDMs expressed on
all or subsets of PBLs. Positive cultures were expanded and cryopre-
served. Supernatants collected at the time of cryopreservation were
screened again to select hybridomas for cloning and establishment of
cell lines producing mAbs of interest. Two-color ﬂow cytometry and a
mAb (H42A, IgG2a) speciﬁc for a highly conserved epitope expressed
on class II MHC molecules was used to identify mAbs speciﬁc for
hamsterMHC II molecules (Table 4) (Davis et al.,1987,1995). ThemAbs
to class II MHC molecules were used in 2-color ﬂow cytometry to
identify mAbs speciﬁc for hLDMs expressed on T or B lymphocytes.
Speciﬁcity was veriﬁed by 2-color ﬂow cytometry that showed the
predicted anti-T and anti-B mAbs labeled mutually exclusive popula-
tions of lymphocytes. Analysis revealed HAB1A recognized molecules
expressed on a subset of HAL3A+ T lymphocytes and that HAB4A and
HAT4A recognized a molecule expressed on a small subset (∼3% of
peripheral blood mononuclear cells) of cells predicted to be dendritic
cells (data not shown). The HAB4A+ HAT4A+ cells were MHC II+.
Hamster lymphoma cell lines established from animals inoculated
with SV40were stainedwith the hybridoma supernatants at optimized
dilutions, followed by anti-mouse isotype-speciﬁc ﬂuorescent con-
jugates [anti-mouse IgG-PE, anti-mouse IgG1-FITC, anti-mouse IgG2a-
PE (Southern Biotechnology Associates)]. Cell lines were stained also
with FITC-conjugated rabbit anti-Syrian hamster IgG (H+L) (Jackson
ImmunoResearch), MAC-2, and MAC-3, rat monoclonal antibodies
speciﬁc for a subpopulation of mouse mononuclear phagocytes,
including macrophages (Cedarlane, Ont., Canada), followed by Alexa
Fluor 488 goat anti-rat IgG (H+L). Cells were analyzed at the Flow
Cytometry Core Facility at Baylor College of Medicine.
Phagocytosis assay
Phagocytosis assays were performed by incubating 2×106 cells in
suspension in 1 ml RPMI growth media with ﬂuorescent polystyrene
microspheres (Molecular Probes, Inc., Eugene, OR) at 30 beads per cell,
a ratio determined to be optimal by dilution experiments (data not
shown). After incubation at 4 or 37 °C for 0–120 min, cells were
transferred to 15-ml conical tubes and washed 5 times with 5 ml of
PBS containing 3% BSA. Cells were then resuspended in 0.5 ml of 1%
BSA in PBS buffer and analyzed by ﬂow cytometry. Additionally, cells
were transferred to a 24-well plate, visualized and photographed
using a Zeiss LSM 51D META confocal microscope (Carl Zeiss,
Germany), and images were processed using LSM Image VisArt (Carl
Zeiss, Inc., Thornwood, NY).
Tumorigenicity assays
Cell lines were harvested from culture, washed, and resuspended
to the desired density in PBS. Cell suspensions in 0.1 ml were
inoculated subcutaneously in the scapular region of weanling
hamsters. Animals were observed twice weekly for tumor growth.
Antibody responses
Serum antibodies against SV40 T-ag were detected by an indirect
immunoﬂuorescence assay using SV40-transformed T-ag-positive
cells as the target. Antibody titers were determined as the highest
serumdilution that gave a detectable T-ag reaction (Sroller et al., 2008).Statistical analysis
Group proportions among animal groups were tested with the
Z test of proportions. Signiﬁcance was deﬁned as a p-value of b0.05.
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